Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Ford

Showing results (401-410 of 458) with videos related to

Pageof 46
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2019
Extending Visit Intervals for Clinically Stable Patients on Antiretroviral Therapy: Multicohort Analysis of HIV Programs in Southern AfricaAndreas D Haas, Leigh F Johnson, Anna Grimsrud, et al.
Plos Medicine|March 24, 2018
HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countriesOlga Tymejczyk, Ellen Brazier, Constantin Yiannoutsos, et al.
Science (New York, N.Y.)|July 17, 2012
Public health. Getting HIV treatment to the most peopleSharonann Lynch, Nathan Ford, Gilles van Cutsem, et al.
Nature Communications|July 2, 2025
Potential impact and cost-effectiveness of long-acting injectable lenacapavir plus cabotegravir as HIV treatment in AfricaAndrew Phillips, Jennifer Smith, Loveleen Bansi-Matharu, et al.
Eclinicalmedicine|December 9, 2020
Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysisSteve Kanters, Marco Vitoria, Michael Zoratti, et al.
The Lancet. HIV|August 9, 2017
Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysisSteve Kanters, Maria Eugenia Socias, Nicholas I Paton, et al.
AIDS (London, England)|December 30, 2025
One-year mortality among adults with advanced HIV in sub-Saharan Africa: a systematic review and meta-analysisThomas C Scheier, Keisha De Gouveia, Mark E Engel, et al.
HIV Medicine|September 26, 2025
Diagnostic accuracy of the WHO clinical staging system for detection of immunologically defined advanced HIV disease: A systematic review and meta-analysisHussein H Twabi, Akitoshi Ueno, Josephine Ives, et al.
Nature Communications|April 17, 2026
Author Correction: Potential impact and cost-effectiveness of long-acting injectable lenacapavir plus cabotegravir as HIV treatment in AfricaAndrew Phillips, Jennifer Smith, Loveleen Bansi-Matharu, et al.
Plos One|February 22, 2014
Systematic review of the performance of HIV viral load technologies on plasma samplesKimberly A Sollis, Pieter W Smit, Susan Fiscus, et al.
Pageof 46

Showing results (401-410 of 458) with videos related to

Sort By:
Pageof 46
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2019
Extending Visit Intervals for Clinically Stable Patients on Antiretroviral Therapy: Multicohort Analysis of HIV Programs in Southern AfricaAndreas D Haas, Leigh F Johnson, Anna Grimsrud, et al.
Plos Medicine|March 24, 2018
HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countriesOlga Tymejczyk, Ellen Brazier, Constantin Yiannoutsos, et al.
Science (New York, N.Y.)|July 17, 2012
Public health. Getting HIV treatment to the most peopleSharonann Lynch, Nathan Ford, Gilles van Cutsem, et al.
Nature Communications|July 2, 2025
Potential impact and cost-effectiveness of long-acting injectable lenacapavir plus cabotegravir as HIV treatment in AfricaAndrew Phillips, Jennifer Smith, Loveleen Bansi-Matharu, et al.
Eclinicalmedicine|December 9, 2020
Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysisSteve Kanters, Marco Vitoria, Michael Zoratti, et al.
The Lancet. HIV|August 9, 2017
Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysisSteve Kanters, Maria Eugenia Socias, Nicholas I Paton, et al.
AIDS (London, England)|December 30, 2025
One-year mortality among adults with advanced HIV in sub-Saharan Africa: a systematic review and meta-analysisThomas C Scheier, Keisha De Gouveia, Mark E Engel, et al.
HIV Medicine|September 26, 2025
Diagnostic accuracy of the WHO clinical staging system for detection of immunologically defined advanced HIV disease: A systematic review and meta-analysisHussein H Twabi, Akitoshi Ueno, Josephine Ives, et al.
Nature Communications|April 17, 2026
Author Correction: Potential impact and cost-effectiveness of long-acting injectable lenacapavir plus cabotegravir as HIV treatment in AfricaAndrew Phillips, Jennifer Smith, Loveleen Bansi-Matharu, et al.
Plos One|February 22, 2014
Systematic review of the performance of HIV viral load technologies on plasma samplesKimberly A Sollis, Pieter W Smit, Susan Fiscus, et al.
Pageof 46